prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Clinical Diagnosis & History: Palpable breast mass, FNA positive malignant cells. Specimens Submitted: 1: SP: Sentinel node #1 level one left axilla(fs). 2: SP: Sentinel node #2 level one left axilla (fs) I. 3: SP: Non sentinel lymph node left axilla. 4: SP: Sentinel node #3, level one left axilla (fs). 5: SP: Left breast mass. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE, (0/1). - ADDITIONAL H/E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CITOKERATINS (AE1:AE3). SHOW NO EVIDENCE OF METASTATIC TUMOR. 2). LYMPH NODE, SENTINEL #2 LEVEL 1 LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE, (0/1). - ADDITIONAL H/E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CYTOKERATINS (AE1:AE3). SHOW NO EVIDENCE OF METASTATIC TUMOR. 3). LYMPH NODE, NON-SENTINEL LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE, (0/1). - BENIGN FIBROADIPOSE TISSUE AND NERVE. 4). LYMPH NODE, SENTINEL #3 LEVEL 1 LEFT AXILLA; EXCISION: ONE BENIGN LYMPH NODE, (0/1). - ADDITIONAL H/E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CITOKERATINS (AE1:AE3). SHOW NO EVIDENCE OF METASTATIC TUMOR. 5). BREAST, LEFT; EXCISION: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, POORLY DIFFERENTIATED,. ASSOCIATED WITH PROMINENT. INFLAMMATORY INFILTRATE, HISTOLOGIC GRADE III/III (SLIGHT OR NO TUBULE. FORMATION), NUCLEAR. GRADE III/III (MARKED VARIATION IN SIZE AND SHAPE), MEASURING 4.5 CM IN. LARGEST DIMENSION. GROSSLY. AN IN SITU COMPONENT IS NOT IDENTIFIED. CALCIFICATIONS ARE PRESENT FOCALLY IN BENIGN BREAST PARENCHYMA. - NO VASCULAR INVASION IS NOTED. - THE MARGINS OF RESECTION ARE NEGATIVE FOR CARCINOMA, (SEE NOTE) . THE. NEAREST (POSTERIOR). MARGIN HAS A CLEARANCE OF 7.7CM MICROSCOPICALLY. THE SKIN IS NOT INVOLVED BY CARCINOMA. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS FIBROADENOMATOID AND BIOPSY. SITE CHANGES. IMMUNOHISTOCHEMICAL STAINS WERE PERFORMED ON FORMALIN-FIXKD TISSUE WITH. THE FOLLOWING. RESULTS FOR INVASIVE CARCINOMA (BLOCK 5 T 8) : ESTROGEN RECEPTOR (6F11,. 0 8 NUCLEAR STAINING. PROGESTERONE RECEPTOR (1E2;. 0 % NUCLEAR STAINING. HER2 (HERCEPTEST;. NEGATIVE (0). (0% OF INVASIVE TUMOR CELLS EXHIBIT COMPLETE MEMBRANOUS STAINING;. UNIFORMITY OF STAINING: ABSENT;. HOMOGENEOUS, DARK CIRCUMFERENTIAL PATTERN: ABSENT). CONTROLS ARE SATISFACTORY. COMMENT: HERCEPTESTTM. IS AN FDA-APPROVED METHOD FOR ASSESSMENT OF. HER2 PROTEIN OVEREXPRESSION IN BREAST CANCER TISSUE ROUTINELY PROCESSED FOR. HISTOLOGICAL EVALUATION. THE HER2 TEST RESULTS ARE REPORTED IN ACCORDANCE. WITH THE ASCO/CAP GUIDELINE RECOMMENDATIONS FOR HER2 TESTING IN BREAST. CANCER (J CLIN ONCOL 2007; 25 (1) :118-145). NOTE: SLIDK 5-L-12 REVIEWED AT DAILY INTRADEPARTMENTAL CASK REVIEW. CONFERENCE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1. Special Studies: Special Stain. Comment. RECUT. Gross Description: MD. 1) The specimen is received fresh for frozen section consultation, labeled. "Sentinel node number 1, level 1, left axilla" and consists of a single pink. tan fatty lymph node measuring 1.8 cm in greatest dimension. Bisected and. entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 2). The specimen is received fresh for frozen section consultation, labeled. "Sentinel node #2, level one, left axilla" and consists of a single pink. tan fatty lymph node measuring 1.6 cm in greatest dimension. Bisected and. entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 3) The specimen is received in formalin, labeled "non-sentinel lymph nodes,. left axilla" and consists of fibroadipose tissue and potential lymph nodes. ranging from 0.4 to 2.2 cm in greatest dimension. All identified lymph. nodes are submitted. Summary of sections: LN potential lymph nodes. BLN- bisected lymph nodes. 4). The specimen is received fresh for frozen section consultation, labeled. "Sentinel node #3, level one, left axilla" and consists of a single pink. tan fatty lymph node measuring 1.1 cm in greatest dimension. Bisected. and. entirely submitted for frozen section. Summary of sections: FSC frozen section control. 5.) The specimen is received fresh, labeled "Left breast mass, short stitch. superior, long -- lateral" and consists of a 14 x 9 x 4.9 cm, piece of. fibrofatty breast tissue with an overlying of 12.5 x 1.3 x 0.2 cm wrinkled. tan-pink skin ellipse. A short stitch indicates the superior margin, and a. long stitch indicates the lateral margin of excision. The specimen is inked. superior -- blue, inferior green, anterior -- red, posterior black,. medial -- orange, and lateral -- yellow. Serial sectioning reveals a 4.5. x. 3.0 x 3.0 cm well-circumscribed, firm, focally hemorrhagic, tan-white. stellate mass located 0.7 cm from the posterior closest margin of excision. Sectioning through the remaining breast tissue reveals an abundant amount of. dense white fibrous tissue with a moderate amount of yellow, lobulated. adipose. The inferior, medial and lateral margins are shaved and entirely. submitted separately. Perpendicular sections of the superior, anterior and. posterior margins are submitted. Representative sections of the tumor and. the remaining tissue are submitted. Summary of sections: SP - superior margin (perpendicular). I - inferior margin. M - medial margin. L - lateral margin. AP - anterior margin (perpendicular). PP - posterior margin (perpendicular). T - tumor. SS - serial sections remaining tissue. Summary of Sections: Part 1: SP: Sentinel node #1 level one left axilla(fs). Block. Sect. site. PCs. 1. FSC. 1. Part 2: SP: Sentinel node #2 level one left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: SP: Non sentinel lymph node left axilla. Block. Sect. Site. PCs. 2. bln. 2. 1. In. 1. Part 4: SP: Sentinel node #3, level one left axilla (fa). Block. Sect. Site. PCs. 1. {not entered}. 1. Part 5: SP: Left breast mass. Block. Sect. Site. PCs. 1. AP. 1. 3. I. 5. 1. L. 1. 1. M. 1. 1. PP. 1. 1. SP. 1. 2. SS. 2. 3. T. 3. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSTS. SP: SENTINEL NODK #1 LEVEL ONE. LEFT AXILLA (FS). BENIGN. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #2 LEVEL ONE. LEFT AXILLA (FS). BENIGN. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #3, LEVEL ONE. LEFT AXILLA (FS). BENIGN. PERMANENT DIAGNOSIS: SAME. MD. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #1 LEVEL ONE. LEFT AXILLA (FS). BENIGN. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #2 LEVEL ONE. LEFT AXILLA (FS). BENIGN. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SUCTION DIAGNOSIS: SP: SENTINEL NODE #3, LEVEL ONE. LEFT AXILLA (FS). BENIGN. PERMANENT DIAGNOSIS: SAME.

expanded version (tokens=2605) : 
 The breast pathology report reveals the following information:

1. Histological classification: Invasive ductal carcinoma, NOS type, poorly differentiated, associated with prominent inflammatory infiltrate, histological grade III/III (slight or no tubule formation), nuclear grade III/III (marked variation in size and shape). There is no in situ component identified.

2. Subtype: Basal.

3. Necrosis: No mention of necrosis in the report.

4. Tumor infiltrating lymphocytes: Prominent inflammatory infiltrate.

5. Histological grade: Grade III/III (slight or no tubule formation).

6. Nuclear grade: Grade III/III (marked variation in size and shape).

7. Lymphovascular invasion: No vascular invasion is noted.

8. Calcification: Calcifications are present focally in benign breast parenchyma.

9. Receptor status: 
- Estrogen receptor: 0% nuclear staining.
- Progesterone receptor: 0% nuclear staining.
- HER2 (HERCEPTEST): Negative (0%). (0% of invasive tumor cells exhibit complete membranous staining; uniformity of staining: absent; homogeneous, dark circumferential pattern: absent).

10. Ancillary testing results: Immunohistochemical stains were performed on formalin-fixed tissue with the following results for invasive carcinoma:
- Estrogen receptor (6F11): 0% nuclear staining.
- Progesterone receptor

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2728) : 
 The report reveals a poorly differentiated basal subtype invasive ductal carcinoma with prominent inflammatory infiltrate, histological grade III/III, nuclear grade III/III without in situ component. No necrosis or vascular invasion is noted, but calcifications are present focally in benign breast parenchyma. ER and PR status are negative, and HER2 expression is negative (0%).

